x
ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2020 > POSTPONED: 8th ESO-SIOP Europe Masterclass in Paediatric Oncology
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

POSTPONED: 8th ESO-SIOP Europe Masterclass in Paediatric Oncology

Not eligible for ESCO credits

28.11.2020  -  03.12.2020

Bucharest, Romania

MASTERCLASS

Paediatric oncology

Important information

On behalf of ESO and SIOP-Europe we would like to inform you that due to the ongoing Coronavirus (COVID-19) crisis we have made the difficult decision to postpone the 8th ESO-SIOP Europe Masterclass in Paediatric Oncology programmed for 28 November - 3 December in Bucharest, Romania.

We deeply regret having to take this decision but we feel that in the current climate we all need to do our part in trying to limit the diffusion of the virus as much as possible and this was the only decision possible considering your role in society as medical staff.

We apologize for any inconvenience caused but we think you’ll all agree that this solution was unavoidable.

The next Masterclass will be held on 27 November - 2 December 2021, in Bucharest, Romania. Further information is available HERE.

Description

Chairs: S. Bielack, DE - B. Morland, UK - C. Stefan, RO/ZA
Host Chair: M. Dragomir, RO


ESO and SIOP-Europe are pleased to announce the eighth Masterclass in Paediatric Oncology. This clinically-oriented educational programme has been designed for young paediatric oncologists, who wish to improve their skills in clinical management of common childhood tumours. It is designed to offer a unique learning experience, providing practice-oriented training and the teaching sessions will focus on the application of the most recent research findings to clinical practice.

LEARNING OBJECTIVES
• Improve knowledge in the field
• Improve skills in dealing with cancer problems as a whole
• Improve knowledge of current clinical practice and state-of-the-art treatment

MAIN TOPICS
• Bone tumours
• Central nervous system tumours
• Leukemia
• Lymphoma
• Neuroblastoma
• Rare tumours
• Soft-tissue sarcoma
• Wilms’ tumour

The Masterclass in Paediatric Oncology is an ESO-SIOP Europe joint event


 

 

Faculty

Andishe Attarbaschi, St. Anna's Kinderspital, Dept. of Paediatrics (Vienna, AT)
André Baruchel, University Hospital Robert Debré (APHP), Pediatric Hematology-Immunology Dept., Paris, FR
Pablo Berlanga, Gustave Roussy, Dept. of Pediatric and Adolescent Oncology (Villejuif, FR)
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology Dpt. (Stuttgart, DE)
Gianni Bisogno, University of Padova, Dept. of Women's and Children's Health (Padova, IT)
Anca Colita, Fundeni Clinical Institute, Paediatric Hem-Onc and BMT Dept. (Bucharest, RO)
Uta Dirksen, University Hospital Essen, Dept. of Pediatrics III, Hematology/Oncology, Essen, DE
François Doz, Institut Curie, Paediatric Oncology Dpt. (Paris, FR)
Monica Desiree Dragomir, University of Medicine 'Carol Davila', Oncology Institute (Bucharest, RO)
Angelika Eggert, Charité University Medicine Berlin, Dept. of Paediatric Oncology/ Haematology (Berlin, DE)
Didier Frappaz, Centre Léon Bérard, Dept. of Adult and Paediatric Neuro-oncology (Lyon, FR)
Jacques Grill, Institut Gustave Roussy, Dept. of Paediatric and Adolescent Oncology (Villejuif, FR)
Henrik Hasle, Aarhus University Hospital, Dept. of Pediatrics (Aarhus N, DK)
Andrew Hoy, Epsom, GB
Christine Mauz-Körholz, Universitätsklinikum Giessen und Marburg, Dept. of Pediatric Hemotology and Oncology, Giessen, DE
Bruce Morland, Birmingham Children's Hospital, Oncology Dpt. (Birmingham, GB)
Daniel Orbach, Curie Institute, Paediatrics, Adolescent, Young Adults SIREDO Center (Paris, FR)
Dominik Schneider, Klinik für Kinder- und Jugendmedizin, Klinikum Dortmund (Dortmund, DE)
Thorsten Simon, University Clinic Köln, Dept. of Pediatric Oncology and Hematology (Köln, DE)
Filippo Spreafico, Fondazione IRCCS Istituto Nazionale Tumori, Dept. of Medical Oncology (Milano, IT)
Cristina Stefan, AMRII (Cape Town, ZA)

General information

ORGANISING SECRETARIAT
Alexandra Zampetti
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 54
e-mail: azampetti@eso.net

Applications:
Dolores Knupfer, dknupfer@eso.net, ph: +41 91 820 0952

CME ACCREDITATION AND CERTIFICATE
The 8th ESO - SIOP Europe Masterclass in Paediatric Oncology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The programme has been granted up to 34 European CME credits (ECMEC). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Participants will receive their certificate of attendance via e-mail after on completion of the evaluation form.

ESCO CREDITS




Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.

A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

Application

PARTICIPANT’S PROFILE
• Age between 30 and 40 years
• 2-4 years’ experience in paediatric oncology
• Involvement in scientific activities and clinical trials
• Fluency in English

PARTICIPATION
Admittance to the Masterclass is by competitive application. The successful applicants are granted free registration but the cost of half-board accommodation and transfer to the course venue is EUR 450.- for the period 6-11 June 2020 and travel will be covered by the participants.
All participants will be expected to reside at the course venue and their full participation is compulsory throughout the course.
The Masterclass will be taught entirely in English and fluency in English is necessary for admission.

SCHOLARSHIPS
Four full tuition scholarships will be offered to applicants from Low and Middle Income Countries (LMIC) as defined by the World Bank. In order to be considered for a scholarship, please submit a letter of motivation requesting consideration. Please note that scholarship recipients will be responsible for arranging their own travel to Bucharest.

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
THE APPLICATION DEADLINE HAS PASSED (12 FEBRUARY 2020)

Programme

28 November

    Arrival
 20:00   Welcome from the Chairs followed by dinner 


 29 November

8:00   Registration     
 8:30   Multiple choice pre-test 
BONE TUMOURS
Session leader: B. Morland, UK
 9:00   Bone sarcomas/case presentations
S. Bielack, DE
 11:00   Coffee break     
 11:15   Bone sarcomas/case presentations
S. Bielack, DE
 12:45   Lunch break                
CNS TUMOURS    
Session leader: M. Dragomir, RO
 13:45   CNS Tumor biology
TBC
14:15   Medulloblastoma
F. Doz, FR
14:45   HGG and LGG
J. Grill, FR
15:30   Ependymoma
D. Frappaz, FR
 16:00   Coffee break
 16:30   Case presentations
 19:30
  Dinner 

 

 30 November

RARE TUMOURS
Session leader: S. Bielack, DE
8:00   Intracranial Germ Cell Tumours 
D. Schneider, DE  
8:30   Germ Cell Tumours   
D. Schneider, DE
9:30   Hepatoblastoma    
B. Morland, UK
10:30   Very rare tumors
D. Schneider, DE
11:00   Coffee break    
11:30   Case presentations
12:30   Lunch break
 13:30   Key note lecture: T-cells  
TBC 
LEUKAEMIA
Session leader: A. Colita, RO
14:30   ALL
M. Schrappe, DE
 15:30   Management of AML
H. Hasle, DK
16:30   Case presentations
20:00   Offsite dinner, Caru' cu Bere

 

 1 December

PARALLEL SESSIONS:         
8:00   Communication workshop (RED GROUP)    
 9:00   Key note lecture: Early phase studies (BLUE GROUP)   
B. Morland, UK
 10:00   Coffee break
SOFT TISSUE SARCOMA
Session leader: C. Stefan, ZA
10:30   Rhabdomyosarcoma    
G. Bisogno, IT
11:30   Non Rhabdo Soft Tissue Sarcoma   
12:30   Questions and discussion   
13:00   Lunch break   
14:00   Case presentations
16:00   Coffee break 
PARALLEL SESSIONS:  
16:30   Communication workshop (BLUE GROUP)   
16:30   Key note lecture: Early phase studies (RED GROUP)
B. Morland, UK  
    Free evening     

 

 2 December

LYMPHOMA
Session leader: C. Stefan, ZA
8:00   Overview: Non-Hodgkin's Lymphoma
A. Attarbaschi, AT
9:00   Overview: Hodgkin's Lymphoma
10:00   Coffee break 
10:30   Case presentations    
12:30   Lunch
13:30   Keynote lecture: How to identify patients who may benefit from personalised medicine
P. Berlanga, FR   
NEUROBLASTOMA
Session leader: B. Morland, UK
15:00   Current approaches in low risk and intermediate risk neuroblastoma   
T. Simon, DE
16:00   Coffee break      
16:30   Current approaches in high-risk and relapse neuroblastoma
A. Eggert, DE  
19:30   Dinner  

 

 3 December

WILMS TUMOUR
Session leader: S. Bielack, DE        
8:00   Overview of renal tumours of childhood and approaches to treatment of Wilms tumour (part I)
F. Spreafico, IT 
8:45   Case presentations   
9:30   Overview of renal tumours of childhood and approaches to treatment of Wilms tumour (part II)
F. Spreafico, IT 
10:15   Case presentations       
 11:30   Multiple choice post-test 
 12:00   Discussion and closure
12:30   Standing brunch
13:00   Group transfer from hotel to airport